
ZNTL EPS Estimates
Zentalis Pharmaceuticals, Inc.
$1.36
-$0.13(-8.72%)
37
Overall
60
Value
27
Tech
26
Quality
Market Cap
$133.64M
Volume
1.21M
52W Range
$1.28 - $6.95
Target Price
$7.80
ZNTL EPS estimates: the consensus estimate for Zentalis Pharmaceuticals, Inc.'s current fiscal year is -$1.80 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
ZNTL EPS Estimates
- EPS estimate, current quarter
- $-0.40
- EPS estimate, next quarter
- $-0.40
- EPS estimate, current year
- $-1.80
- EPS estimate, next year
- $-1.75
- EPS growth, 3-year
- +24.74%
| Fiscal year | EPS |
|---|---|
| 2025 | $-1.91 |
| 2024 | $-2.33 |
| 2023 | $-4.47 |
| 2022 | $-4.48 |
| 2021 | $-3.72 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ZNTL | $1.36 | -8.7% | 1.21M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Zentalis Pharmaceuticals, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW